open navigation

Board of Directors

Return to Common Sensing

James White

James White

Board Chairman: James White is a co-founder of Common Sensing and currently serves as Chairman of the Board and VP New Business. James received his B.S. Engineering from MIT in 2010 and M.S. from MIT in 2012, where he worked on the software, electrical, and mechanical design and control of automatic ocular jet injectors in Ian Hunter’s Bioinstrumentation Lab. Having been instilled with a strong passion for improving lives through better medical devices, James and Rich invented Gocap around their kitchen table in January 2012. Outside of medical devices, James develops video games, leads mountaineering trips, and advises/invests in technology companies.

Kevin Schmid

Kevin Schmid

Mr. Schmid is the Chief Executive Officer at Common Sensing, Inc. Common Sensing is a Cambridge, MA based company that designs and manufactures disposable injector pen dose monitoring and reporting technology. Since November 2015 Mr. Schmid serves as a member of the Board of Directors for Common Sensing, Inc. and has previously held the position of Chief Operating Officer at Common Sensing. Since January 2018 Mr. Schmid serves as a member of the Board of Directors for Sorrel Medical Ltd. Sorrel Medial is an Israel based company that develops wearable, pre-filled cartridge-based drug delivery platform technology. Mr. Schmid earned a Bachelor of Science in Mechanical Engineering from Clarkson University and a Master of Business Administration from Sacred Heart University.

Richard Whalley

Richard Whalley

Richard Whalley is a creative technologist and healer focused on leading diverse teams to build life-changing products and experiences that serve people in need. Rich is an MIT engineer and before co-founding Common Sensing, he consulted for biotech startups to help them tell their stories to investors. Catch him outside of work and you may be able to find him drumming, playing soccer, or meditating.

Robbie Greenglass

Robbie Greenglass

Robbie is an investor at Waterline Ventures. Robbie founded Waterline Ventures in 2014, focusing on investments in healthcare technology. Robbie has also spent time as the Vice President of Business Development at Shields Health Solutions, a hospital services company in the specialty pharmacy space. Prior to founding Waterline, Robbie was an investor at Highland Capital Partners, and helped launch Causeway Media Partners, a sports technology investment fund. Prior to Highland, Robbie was an investment banker in the Healthcare Group at Oppenheimer & Co. and CIBC World Markets. Robbie received a B.A. from Brown University and a M.B.A. from Harvard Business School.

Patrick Flynn

Patrick Flynn

Mr. Flynn is an entrepreneur with more than 35 years of senior executive experience. He has provided leadership to numerous successful organizations including start-ups and Fortune 100 companies and has served in a variety of roles, including CEO, COO, CFO, and advisor. In addition to Mr. Flynn’s role as an advisor and board member to Common Sensing, he currently serves as the COO of Good Measures where he is responsible for the day-to-day operations of the company’s innovative healthcare and nutrition services. In 2018 Mr. Flynn joined the board of NeuroRx, which recently received an FDA “Breakthrough Therapy designation” for its drug, NRX-101, introducing a new class of antidepressants for bipolar suicidality, PTSD and depression.

John Dwyer

John Dwyer

Mr. Dwyer first became a CEO at the age of 30. In the following years, he held “C” level positions in six emerging growth companies in the healthcare industry. John previously served as the co-founder and Chairman of Telcare, Inc. and CEO of e-Medex, Inc., which later merged with Active Health Management to become the leading provider of health information management services. He is President of the Global Alzheimer’s Platform Foundation, and co-founded Us Against Alzheimer’s. John is on the Board of Directors for various private and not-for-profit organizations and is a graduate of Marquette University and Cornell Law School.